For example, if you started a GLP-1 in September 2024 with a BMI of 37 but in July 2026 youve lost weight and now have a BMI of 34, the prescriber should attest in the prior authorization request that you met the BMI criteria of 35 or over when the GLP-1 therapy started
Top Medical Alternatives to Semaglutide If you are looking for a medical alternatives to semaglutide for weight loss, you may try some of the FDA-approved medications available in the market
There is not currently a generic form of Wegovy this treatment is too new to be replicated
The tracker works wherever your prescription comes from, and it keeps working if you switch molecules later
The action of semaglutide GLP-1 is to lower high blood sugar by increasing insulin release, decreasing glucagon release, and delaying gastric emptying
Findings are preliminary and should be interpreted as an early signal rather than a basis for changing clinical practice